ArticleCancer immunology, immunotherapy : CII2025

Preclinical evaluation of CAR-T cell immunotherapy with a fully human EpCAM-specific scFv against pancreatic cancer.

Ying-Ying Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.